Christopher P. Laudeman

869 total citations
15 papers, 409 citations indexed

About

Christopher P. Laudeman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Christopher P. Laudeman has authored 15 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Christopher P. Laudeman's work include Neuropeptides and Animal Physiology (5 papers), Receptor Mechanisms and Signaling (3 papers) and Chemical Synthesis and Analysis (2 papers). Christopher P. Laudeman is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Receptor Mechanisms and Signaling (3 papers) and Chemical Synthesis and Analysis (2 papers). Christopher P. Laudeman collaborates with scholars based in United States and Iran. Christopher P. Laudeman's co-authors include Kenneth D. James, Jerzy R. Szewczyk, Steve Smith, Navdeep B. Malkar, Xi Liang, Steven M. Sparks, Grace Chen, Channa Jayawickreme, Dana P. Danger and Stephen Jenkinson and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Christopher P. Laudeman

15 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher P. Laudeman United States 10 188 125 94 64 44 15 409
M. Angeles Cabello Spain 12 239 1.3× 44 0.4× 71 0.8× 43 0.7× 78 1.8× 16 439
Paula M. Brito Portugal 11 257 1.4× 57 0.5× 53 0.6× 35 0.5× 23 0.5× 15 571
Yubo Chai United States 14 296 1.6× 133 1.1× 53 0.6× 17 0.3× 14 0.3× 25 606
А. А. Озеров Russia 13 203 1.1× 95 0.8× 87 0.9× 153 2.4× 11 0.3× 79 505
Aurelio A. Moya‐García Spain 15 318 1.7× 80 0.6× 25 0.3× 56 0.9× 35 0.8× 30 585
John A. Wos United States 13 249 1.3× 87 0.7× 39 0.4× 285 4.5× 12 0.3× 34 565
R.J. George United States 4 125 0.7× 102 0.8× 91 1.0× 36 0.6× 35 0.8× 4 459
Esteban Santiago Spain 13 241 1.3× 70 0.6× 29 0.3× 52 0.8× 12 0.3× 38 473
W.-G. Su Canada 7 188 1.0× 56 0.4× 41 0.4× 55 0.9× 19 0.4× 8 402
Inés Maestro Spain 10 234 1.2× 200 1.6× 137 1.5× 82 1.3× 14 0.3× 11 613

Countries citing papers authored by Christopher P. Laudeman

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Laudeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Laudeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Laudeman more than expected).

Fields of papers citing papers by Christopher P. Laudeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Laudeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Laudeman. The network helps show where Christopher P. Laudeman may publish in the future.

Co-authorship network of co-authors of Christopher P. Laudeman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Laudeman. A scholar is included among the top collaborators of Christopher P. Laudeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Laudeman. Christopher P. Laudeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Laudeman, Christopher P., et al.. (2024). Identification of Novel GANT61 Analogs with Activity in Hedgehog Functional Assays and GLI1-Dependent Cancer Cells. Molecules. 29(13). 3095–3095. 3 indexed citations
2.
Donlic, Anita, et al.. (2022). R-BIND 2.0: An Updated Database of Bioactive RNA-Targeting Small Molecules and Associated RNA Secondary Structures. ACS Chemical Biology. 17(6). 1556–1566. 43 indexed citations
3.
Tarpley, Michael, Jose Roques, Christopher P. Laudeman, et al.. (2021). Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. European Journal of Pharmaceutical Sciences. 162. 105821–105821. 29 indexed citations
4.
Compton, Sarah A., David L. Musso, Christopher P. Laudeman, et al.. (2018). N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice. PLoS ONE. 13(10). e0204605–e0204605. 13 indexed citations
5.
James, Kenneth D., et al.. (2016). CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility. The Journal of Antibiotics. 70(2). 130–135. 77 indexed citations
7.
Sparks, Steven M., Grace Chen, Jon L. Collins, et al.. (2014). Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). Bioorganic & Medicinal Chemistry Letters. 24(14). 3100–3103. 94 indexed citations
8.
James, Kenneth D., et al.. (2014). Biafungin (CD101), a Novel Echinocandin, Displays a Long Half-life in the Chimpanzee, Suggesting a Once-Weekly IV Dosing Option. 4 indexed citations
9.
Szewczyk, Jerzy R., Christopher P. Laudeman, Douglas J. Minick, et al.. (2010). A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity. Bioorganic & Medicinal Chemistry. 18(5). 1822–1833. 3 indexed citations
10.
Daniels, Alejandro J., David N. Deaton, Aaron S. Goetz, et al.. (2008). Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead. Bioorganic & Medicinal Chemistry Letters. 18(20). 5451–5455. 10 indexed citations
11.
Szewczyk, Jerzy R. & Christopher P. Laudeman. (2003). CCK1R Agonists: A Promising Target for the Pharmacological Treatment of Obesity. Current Topics in Medicinal Chemistry. 3(8). 837–854. 33 indexed citations
12.
Seltzman, Herbert H., et al.. (1998). Protection of the allylic alcohol double bond from catalytic reduction in the preparation of [1-3H]morphine and [1-3H]codeine. Journal of Labelled Compounds and Radiopharmaceuticals. 41(9). 811–821. 8 indexed citations
14.
Seltzman, Herbert H., et al.. (1994). Metallation/reduction as a new approach to tritium labeling. The synthesis of [3H]ibogaine. Journal of Labelled Compounds and Radiopharmaceuticals. 34(4). 367–375. 4 indexed citations
15.
Setzer, William N., Shahrara Afshar, Norman Burns, et al.. (1990). Synthesis of mesocyclic and macrocyclic polythioethers using the cesium dithiolate technique. Heteroatom Chemistry. 1(5). 375–387. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026